Category: Cancer Treatment
North America Cancer Treatment
-
Prostate Cancer Diagnostics
... at a CAGR of 13.3% over the analysis period 2024-2030. Preliminary, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$10.0 Billion by the end of the ... Read More
-
2025 North America Cancer Biomarkers Market Forecast (2025-2030 Outlook)-High Tech Outlook Report
... Forecast (2026-2031 Outlook)-High Tech Outlook Report, published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market. The product or service category is within the Medical Device Manufacturing industry. NAICS CAN1310 Read More
-
2025 United States Cancer Biomarkers Market Forecast (2025-2030 Outlook)-High Tech Outlook Report
... Forecast (2026-2031 Outlook)-High Tech Outlook Report, published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market. The product or service category is within the Medical Device Manufacturing industry. NAICS CAN1310 Read More
-
U.S. Cervical Cancer Laboratory Testing Market: Focus on Test Type, and Region-Level Analysis - Analysis and Forecast, 2025-2035
... to identify cell changes and HPV DNA testing to detect the presence of high-risk human papillomavirus strains. These tests help in early detection, allowing for timely intervention and prevention. Various factors such as the increasing ... Read More
-
Elastomeric Infusion Pumps Market, by Product Type (Variable Rate Elastomeric Pumps, Continuous Rate Elastomeric Pumps), by Treatment (Pain Management, Antibiotic/Antiviral, Chemotherapy, Others), by End User (Ambulatory Surgical Centers, Clinics, Home Care Settings, Hospitals, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
... medical devices used for drug infusion. The process of infusion is carried out with the help of consistent pressure created in the elastomeric layer present in the pump which is controlled with the help of ... Read More
-
Global Cancer Therapeutics And Biotherapeutics Market, By Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Head and Neck Cancer, Giloblastoma, Malignant Meningioma, Mesothelioma, Melanoma, and Others), By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Hormone Therapy, Biotherapy, and Others), By Application (Therapeutics, Drug Discovery, Gene therapy, IVF treatment, Cell therapy, and Research & Development), By End User (Hospitals & Clinics, Cancer Care Centers, Research Institutes, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... the human immune system or block cancer cell growth using monoclonal antibodies or other agents. Targeted cancer therapies focus on specific molecular targets found in cancer cells unlike chemotherapy which affects all rapidly dividing normal ... Read More
-
Global Analgesics Market, By Drug Type (Opioid, Non-opioid, Compound medication), By Route of Administration (Oral, Parenteral, Transdermal, Others), By Application (Musculoskeletal, Surgical and Trauma, Cancer, Neuropathic, Migraine, Obstetrical, Fibromyalgia, Pain due to Burns , Dental/Facial, Pediatric, Others), By Pain Type (Acuteand Chronic ), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... and higher stress levels have significantly increased several pain-related ailments like backache, arthritis, and migraines among others. Technological advancements in drug delivery systems and formulation development have boosted demand for novel analgesic medications with improved ... Read More
-
Chronic Pain Market, By Drug Class (Opioids, Non-steroidal anti-inflammatory drugs (NSAIDS), Anticonvulsants, Antidepressants, and Others), By Indication (Neuropathic pain, Arthritis pain, Chronic back pain, Cancer pain, Migraine, Fibromyalgia, and Others), By Application (Musculoskeletal, Neuropathy, Oncology, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... neurological disorders and fibromyalgia among others. Sedentary lifestyles and rising chronic diseases can increase the prevalence of chronic pain globally. It negatively impacts quality of life by limiting mobility and daily functioning. Global chronic pain ... Read More
-
Chemotherapy Market, By Drugs (Alkylating agents, Antimetabolites, Anti-tumor Antibiotics, and Others), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer, Liver Cancer, and Others), By Route of Administration (Oral, Parenteral, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... divide, and spread more rapidly than normal cells. Chemotherapy is used to treat many types of cancers including breast cancer, lung cancer, colorectal cancer, lymphoma, leukemia, bladder cancer, testicular cancer, ovarian cancer, and others. It ... Read More
-
U.S. Sterile Injectables Market, By Molecule Type (Large Molecule and Small Molecule), By Drug Type (Monoclonal Antibody (mAbs), Cytokines, Insulin, Peptide Hormones, Vaccines, and Others), By Therapeutic Application (Cancer, Metabolic Disorder, Cardiovascular Diseases, Infectious Diseases, Musculoskeletal Disorders, and Others), By Route of Administration (Subcutaneous, Intravenous, Intramuscular, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
... that are administered via various injection routes such as intravenous, intramuscular, subcutaneous, and others in their final sterile form for healing or preventing medical conditions. The rising prevalence of chronic diseases like cancer, diabetes, autoimmune ... Read More
-
Biomarker Research Services Market, By Service Type (Biomarker Research Services and Companion Diagnostics (CDx) Research Services), By Disease Indication (Cancer, Cardiovascular Disorders, Infectious Diseases, Neurological Disorders, Immunological Disorders, and Others), By End User (Hospitals, Diagnostic Centers, Specialty Centers, and Research Institutions),By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa).
... from 2025 to 2032. The global biomarker research services market has been gaining significant traction over the recent past, owing to rising penetration of precision medicine and personalized healthcare. Biomarkers play a crucial role in ... Read More
-
2025 North America Cancer Diagnostics Market in the USA, Canada, Mexico - 2024 Supplier Shares and Strategies by Country, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... LeadingMarketResearch.com provides information and analysis not available from any other published source , including 2024 supplier strategies and shares by country, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides ... Read More
-
2025 US Cancer Diagnostics Market - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... any other published source , including 2024 supplier strategies and shares, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies ... Read More
-
2025 Canada Cancer Diagnostics Market - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... any other published source , including 2024 supplier strategies and shares, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies ... Read More
-
2025 Mexico Cancer Diagnostics Market - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... any other published source , including 2024 supplier strategies and shares, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies ... Read More
-
2025 Global Cancer Diagnostics Market in the USA, Europe, Japan - 2024 Supplier Shares and Strategies by Country, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... provides information and analysis not available from any other published source , including 2024 supplier strategies and shares by country, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides a ... Read More
-
2024-2029 North America Immunodiagnostic/Immunoassay Analyzers and Reagents - USA, Canada, Mexico - 2024 Supplier Shares and Competitive Analysis, 2024-2029 Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Centralized and POC Tests - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers, Market Challenges and Risks
... Special Chemistry Centralized and POC Tests - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers, Market Challenges and Risks This new 3-country report from LeadingMarketResearch.com . This report provides a granular strategic analysis of ... Read More
-
2024-2029 Global Immunodiagnostic/Immunoassay Analyzers and Reagents - USA, Europe, Japan - 2024 Supplier Shares and Competitive Analysis, 2024-2029 Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Centralized and POC Tests - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers, Market Challenges and Risks
... Chemistry Centralized and POC Tests - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers, Market Challenges and Risks LeadingMarketResearch.com's new report is a seven-country strategic analysis of major business opportunities emerging in the immunodiagnostic ... Read More
-
2024-2029 Canada Immunodiagnostic/Immunoassay Analyzers and Reagents - 2024 Supplier Shares and Competitive Analysis, 2024-2029 Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Centralized and POC Tests - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers, Market Challenges and Risks
... Tests - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers, Market Challenges and Risks This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities ... Read More
-
2024-2029 US Immunodiagnostic/Immunoassay Analyzers and Reagents - 2024 Supplier Shares and Competitive Analysis, 2024-2029 Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Centralized and POC Tests - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers, Market Challenges and Risks
... Tests - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers, Market Challenges and Risks LeadingMarketResearch’s new report is a study of the major business opportunities emerging in the U.S. immunodiagnostic market during the next ... Read More
-
T-Cell Therapy Market by Type of Therapy (CAR-T, TCR, and TIL), Target Indications (Acute Lymphoblastic Leukemia, Non-Hodgkin’s Lymphoma, Melanoma, Bladder Cancer, Lung Cancer, Head, and Neck Cancer, Multiple Myeloma, Sarcoma, Chronic Lymphocytic Leukemia, Ovarian Cancer, Esophageal Cancer, Colorectal Cancer, Nasopharyngeal Carcinoma, Hepatocellular Carcinoma, Acute Myeloid Leukemia, and Renal Cell Carcinoma), Target Antigens (CD19, BCMA, CD19/22, EGFR, NY-ESO-1, gp100, p53, EBV, MUC1, WT-1, and Others), and Key Geographical Regions (North America, Europe and Asia Pacific, Latin America, Middle East, and North Africa): Industry Trends and Global Forecasts, Till 2035
... Esophageal Cancer, Colorectal Cancer, Nasopharyngeal Carcinoma, Hepatocellular Carcinoma, Acute Myeloid Leukemia, and Renal Cell Carcinoma), Target Antigens (CD19, BCMA, CD19/22, EGFR, NY-ESO-1, gp100, p53, EBV, MUC1, WT-1, and Others), and Key Geographical Regions (North America, ... Read More
-
Global TCR Therapy Market by Target Indication (Nasopharyngeal Carcinoma, Multiple Myeloma, Head and Neck Carcinoma, Sarcoma, Melanoma, Acute Myeloid Leukemia, Lung Cancer, Ovarian Cancer, and Merkel Cell Cancer), Target Antigen (NY-ESO-1, EBV, gp100, and others), Key Players and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World): Industry Trends and Global Forecasts, Till 2035
... Key Players and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World): Industry Trends and Global Forecasts, Till 2035 Global TCR Therapy Market: Overview As ... Read More
-
Clinical Trials Outsourcing Market Size, Share, and Analysis, By Phase (Phase I, Phase II, Phase III, Phase IV), By Application (Cancer, Cardiovascular Diseases, Nervous System Diseases, Infectious Diseases, Musculoskeletal Disease, Gastroenterology Diseases, and Others), By Services Type (Protocol Designing, Site Identification, Patient Recruitment, Laboratory Services, Bioanalytical Testing Services, Clinical Trial Data Management Services, and Others), By End-User (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
... Services Type (Protocol Designing, Site Identification, Patient Recruitment, Laboratory Services, Bioanalytical Testing Services, Clinical Trial Data Management Services, and Others), By End-User (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, and Others), By Region (North America, ... Read More
-
Brachytherapy Market Research Report Information, By Product (Afterloaders & Applicators, Radioactive Seeds, Electronic Brachytherapy, Imaging Systems, and Others), By Type (High Dose-Rate (HDR) Brachytherapy, Low Dose-Rate (LDR) Brachytherapy), By Technique (Interstitial Brachytherapy, Intracavitary Brachytherapy), By Indication (Prostate Cancer, Breast Cancer, Cervical Cancer, Skin Cancer, and Others), By End-Users (Hospitals & Specialty Clinics, Cancer Treatment Centers, and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) Industry Forecast Till 2032
... Indication (Prostate Cancer, Breast Cancer, Cervical Cancer, Skin Cancer, and Others), By End-Users (Hospitals & Specialty Clinics, Cancer Treatment Centers, and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) Industry ... Read More
-
2024-2029 US Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - 2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for 100 Tests - Abused Drugs, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Assays - High-Growth Opportunities for Suppliers, Competitive Analysis and Growth Strategies, Latest Technologies and Instrumentation Pipeline
... Opportunities for Suppliers, Competitive Analysis and Growth Strategies, Latest Technologies and Instrumentation Pipeline LeadingMarketResearch’s new report is a study of the major business opportunities emerging in the U.S. immunodiagnostic market during the next five years. ... Read More
Research Assistance
